FRONTIER CAPITAL MANAGEMENT CO LLC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 351173
Boston, MA
Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,815,920
-$30,976,620 QoQ
Shares Held
277,279
-46.4% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#46
of 640 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $975,847,387 across 22 Biotechnology names. JAZZ ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,373,057 | $102,265,285 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,847,936 | $95,092,583 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
740,866 | $84,955,104 | |
| 4 | INSM |
INSMED Inc
|
795,242 | $84,788,702 | |
| 5 | PVLA |
Palvella Therapeutics, Inc.
|
478,833 | $73,175,259 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
277,279 | $66,815,920 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
254,280 | $62,240,115 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,070,740 | $57,269,301 |
All Filings in JAZZ
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,815,920 | 277,279 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $97,792,540 | 517,284 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,974,170 | 182,201 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,075,486 | 38,509 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,209,355 | 39,666 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,939,431 | 39,786 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,310,496 | 35,002 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,671,054 | 23,975 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,605,919 | 24,416 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,003,483 | 33,246 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,359,951 | 59,837 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,567,968 | 58,467 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,008,016 | 40,397 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,712,927 | 59,543 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,661,373 | 230,126 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,435,831 | 160,821 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,096,235 | 77,535 | Shares | Sole | 2022-07-20 | |
| No filing history on record for this holder in this stock. | ||||||